2026/6 - Oncology medicines and immunomodulators

Summary

This is a framework agreement for medicines in the oncology and immunomodulator categories. The contract is for supplies, with an estimated maximum value of EUR 2,038,568,211.52 and a planned duration of 12 months. The tender is open, electronic submission is required, and price is the only award criterion. The notice also indicates that e-invoicing is allowed and electronic ordering is used.